DepressionMental HealthPharmacologyStrictly Clinical

Treatment-resistant depression and the T-rex combination

Share
Download PDF
By: Gryan Garcia, PhD, PsyD, FNP-BC, PMHNP-BC; Christy Cotner, DNP, FNP-C, PMHNP-BC; and Robert Spano, DNP, FNP-C, PMHNP-BC

The T-Rex combination of Trintellix (vortioxetine) and Rexulti (brexpiprazole) targets multiple neurotransmitter systems, providing a novel and effective approach for managing treatment-resistant depression.

This article is available to American Nurses Association members and ANJ subscribers only.
Already a member? Log in here

Let Us Know What You Think

Test Your Knowledge

Which of the following best describes Wegovy’s FDA-approved use?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts